# Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects

> **NCT05481385** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 48 (estimated)

## Conditions studied

- Pharmacokinetics
- Safety

## Interventions

- **BEHAVIORAL:** Reference preparation-Reference preparation-Test Preparation
- **BEHAVIORAL:** Reference preparation-Test Preparation-Reference preparation
- **BEHAVIORAL:** Test Preparation-Reference preparation-Reference preparation

## Key facts

- **NCT ID:** NCT05481385
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-15
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-12-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481385, "Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05481385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*